Pharmacological treatment of binge eating disorder: update review and synthesis.

ABSTRACT:

Introduction

Binge eating disorder (BED), a formal eating disorder diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), is characterized by recurrent binge eating, marked distress about binge eating, and the absence of extreme weight compensatory behaviors. BED is more prevalent than other eating disorders, with broader distribution across age, sex and ethnic/racial groups, and is associated strongly with obesity and heightened risk for psychiatric/medical comorbidities.

Areas covered

This article provides an overview of pharmacotherapy for BED with a focus on Phase III randomized controlled trials (RCTs). The search with minimal methodological inclusion requirements yielded 22 RCTs investigating several different medication classes; most were phar

SUBMITTER: Reas DL 

PROVIDER: S-EPMC4491373 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature